Education
About Us
Working with TipRanks
Follow Us
Tianjin TEDA Biomedical Engineering Co. Ltd. Class H (HK:8189)
:8189
8189 Stock Chart & Stats
HK$0.40
HK$0.00(0.00%)
At close: 4:00 PM EST
HK$0.40
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$0.27 - HK$0.65
Previous CloseN/A
Volume305.00K
Average Volume (3M)1.68M
Market Cap
HK$640.17M
Enterprise ValueN/A
Total Cash (Recent Filing)HK$186.13M
Total Debt (Recent Filing)HK$112.58M
Price to Earnings (P/E)―
Beta<0.01
Next Earnings
Mar 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding1,436,400,000
10 Day Avg. Volume2,135,000
30 Day Avg. Volume1,681,333
Financial Highlights & Ratios
PEG Ratio-0.19
Price to Book (P/B)24.48
Price to Sales (P/S)1.41
P/FCF Ratio-18.81
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
8189 FAQ
What was Tianjin TEDA Biomedical Engineering Co. Ltd. Class H’s price range in the past 12 months?
Tianjin TEDA Biomedical Engineering Co. Ltd. Class H lowest stock price was HK$0.27 and its highest was HK$0.65 in the past 12 months.
What is Tianjin TEDA Biomedical Engineering Co. Ltd. Class H’s market cap?
Tianjin TEDA Biomedical Engineering Co. Ltd. Class H’s market cap is HK$640.17M.
When is Tianjin TEDA Biomedical Engineering Co. Ltd. Class H’s upcoming earnings report date?
Tianjin TEDA Biomedical Engineering Co. Ltd. Class H’s upcoming earnings report date is Mar 26, 2026 which is in 108 days.
How were Tianjin TEDA Biomedical Engineering Co. Ltd. Class H’s earnings last quarter?
Currently, no data Available
Is Tianjin TEDA Biomedical Engineering Co. Ltd. Class H overvalued?
According to Wall Street analysts Tianjin TEDA Biomedical Engineering Co. Ltd. Class H’s price is currently Overvalued.
Does Tianjin TEDA Biomedical Engineering Co. Ltd. Class H pay dividends?
Tianjin TEDA Biomedical Engineering Co. Ltd. Class H does not currently pay dividends.
What is Tianjin TEDA Biomedical Engineering Co. Ltd. Class H’s EPS estimate?
Tianjin TEDA Biomedical Engineering Co. Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Tianjin TEDA Biomedical Engineering Co. Ltd. Class H have?
Tianjin TEDA Biomedical Engineering Co. Ltd. Class H has 1,436,400,000 shares outstanding.
What happened to Tianjin TEDA Biomedical Engineering Co. Ltd. Class H’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Tianjin TEDA Biomedical Engineering Co. Ltd. Class H?
Currently, no hedge funds are holding shares in HK:8189
Tianjin TEDA Biomedical Engineering Co. Ltd. Class H Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
11.11%
12-Months-Change
Fundamentals
Return on Equity
-44.61%
Trailing 12-Months
Asset Growth
36.52%
Trailing 12-Months
Company Description
Tianjin TEDA Biomedical Engineering Co. Ltd. Class H
Tianjin TEDA Biomedical Engineering Co. Ltd. Class H (8189) is a leading Chinese company focused on the development, production, and sales of advanced biomedical engineering products. The company operates primarily in the healthcare sector, specializing in medical devices, biopharmaceuticals, and innovative healthcare solutions. With a commitment to enhancing patient outcomes and advancing medical technology, TEDA Biomedical Engineering offers a range of products including diagnostic equipment, therapeutic devices, and bio-materials.
Tianjin TEDA Biomedical Engineering Co. Ltd. Class H (8189) Earnings & Revenues
Technical Analysis
China BlueChemical
―
Sinofert Holdings
―
China XLX Fertiliser Ltd.
―
Ko Yo Chemical (Group) Limited
―
Century Sunshine Group Holdings Limited
―